Showing results (161-170 of 236) with videos related to
Sort By:
Pageof 24
Journal of Cellular Biochemistry|July 1, 2016
Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug ScreeningTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.Oncotarget|October 27, 2016
Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-cateninShingo Shimozaki, Norio Yamamoto, Takahiro Domoto, et al.Anticancer Research|April 28, 2025
Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal FibroblastsYohei Asano, Qinghong Han, Kohei Mizuta, et al.Journal of Cellular Biochemistry|January 21, 2017
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse ModelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2011
Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis CYo-Hei Aoki, Shogo Ohkoshi, Satoshi Yamagiwa, et al.Cell Cycle (Georgetown, Tex.)|November 11, 2016
Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Translational Oncology|February 27, 2019
Osimertinib Regresses an EGFR-Mutant Cisplatinum- Resistant Lung Adenocarcinoma Growing in the Brain in Nude MiceTakashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, et al.Cancer Chemotherapy and Pharmacology|November 10, 2019
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Norihiko Sugisawa, Jun Yamamoto, et al.Anticancer Research|May 31, 2024
DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal FibroblastsSei Morinaga, Qinghong Han, Yutaro Kubota, et al.Cancer Science|December 7, 2019
Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcomaKensaku Abe, Norio Yamamoto, Takahiro Domoto, et al.Pageof 24